English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
European Commission
Russell Boniface
| Sep 13, 2017
Merck's Keytruda wins European approval as bladder cancer treatment
Tabitha Fleming
| Jun 2, 2017
European Commission approves dinutuximab beta for treating high-risk neuroblastoma
Robert Hadley
| Apr 5, 2017
European Commission OKs Pfizer’s Xeljanz for rheumatoid arthritis treatment
Kyle Perrotti
| Mar 17, 2017
European Reference Networks help patients with complex diseases find diagnosis, treatment
Amanda Rupp
| Aug 9, 2016
Keytruda gains EC approval as advanced non-small cell lung cancer treatment
Amanda Rupp
| Jun 8, 2016
Positive CHMP opinion granted for Amgen relapsed multiple myeloma treatment
Amanda Rupp
| Jun 7, 2016
CHMP gives positive opinion of short bowl syndrome pediatric medicine
Amanda Rupp
| Jun 2, 2016
Imbruvica gains approval for treating chronic lymphocytic leukemia
Trending
+
Technology/Innovation
Patient Daily
| May 8, 2025
Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+
Technology/Innovation
Patient Daily
| May 7, 2025
OTO Forum 2025 highlights innovation in ENT
+
Pharmaceuticals
Patient Daily
| May 8, 2025
Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+
Regulatory
Patient Daily
| May 12, 2025
Turning Point USA founder: 'Big pharma’s lobbying of Washington DC has long allowed them to price gouge Americans'
